| Safety and efficacy of nanocurcumin as add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a pilot randomized clinical trial M Ahmadi, E Agah, S Nafissi, MR Jaafari, MH Harirchian, P Sarraf, ... Neurotherapeutics 15 (2), 430-438, 2018 | 103 | 2018 |
| Efficacy and safety of oral ketamine versus diclofenac to alleviate mild to moderate depression in chronic pain patients: a double-blind, randomized, controlled trial M Jafarinia, M Afarideh, A Tafakhori, M Arbabi, A Ghajar, AA Noorbala, ... Journal of affective disorders 204, 1-8, 2016 | 101 | 2016 |
| The synergistic effects of ω-3 fatty acids and nano-curcumin supplementation on tumor necrosis factor (TNF)-α gene expression and serum level in migraine patients M Abdolahi, A Tafakhori, M Togha, AA Okhovat, F Siassi, MR Eshraghian, ... Immunogenetics 69, 371-378, 2017 | 100 | 2017 |
| An inverse association between serum vitamin D levels with the presence and severity of impaired nerve conduction velocity and large fiber peripheral neuropathy in diabetic … A Alamdari, R Mozafari, A Tafakhori, S Faghihi-Kashani, N Hafezi-Nejad, ... Neurological Sciences 36, 1121-1126, 2015 | 89 | 2015 |
| Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis E Agah, A Zardoui, A Saghazadeh, M Ahmadi, A Tafakhori, N Rezaei PLoS One 13 (1), e0190252, 2018 | 80 | 2018 |
| Effects of early intervention of swallowing therapy on recovery from dysphagia following stroke J Bakhtiyari, P Sarraf, N Nakhostin-Ansari, A Tafakhori, J Logemann, ... Iranian journal of neurology 14 (3), 119, 2015 | 78 | 2015 |
| A clinical and molecular genetic study of 50 families with autosomal recessive parkinsonism revealed known and novel gene mutations S Taghavi, R Chaouni, A Tafakhori, LJ Azcona, SG Firouzabadi, ... Molecular neurobiology 55, 3477-3489, 2018 | 77 | 2018 |
| Neurological manifestations as the predictors of severity and mortality in hospitalized individuals with COVID-19: a multicenter prospective clinical study M Amanat, N Rezaei, M Roozbeh, M Shojaei, A Tafakhori, A Zoghi, ... BMC neurology 21, 1-12, 2021 | 75 | 2021 |
| Memantine for prophylactic treatment of migraine without aura: A randomized double‐blind placebo‐controlled study R Noruzzadeh, A Modabbernia, V Aghamollaii, M Ghaffarpour, ... Headache: The Journal of Head and Face Pain 56 (1), 95-103, 2016 | 71 | 2016 |
| Early versus late spinal decompression surgery in treatment of traumatic spinal cord injuries; a systematic review and meta-analysis M Yousefifard, V Rahimi-Movaghar, M Baikpour, P Ghelichkhani, ... Emergency 5 (1), 2017 | 67 | 2017 |
| Does oral administration of ketamine accelerate response to treatment in major depressive disorder? Results of a double-blind controlled trial S Arabzadeh, E Hakkikazazi, N Shahmansouri, A Tafakhori, A Ghajar, ... Journal of affective disorders 235, 236-241, 2018 | 65 | 2018 |
| A novel combination of ω-3 fatty acids and nano-curcumin modulates interleukin-6 gene expression and high sensitivity C-reactive protein serum levels in patients with migraine … M Abdolahi, P Sarraf, MH Javanbakht, NM Honarvar, M Hatami, N Soveyd, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2018 | 64 | 2018 |
| Transplantation of olfactory ensheathing cells on functional recovery and neuropathic pain after spinal cord injury; systematic review and meta-analysis B Nakhjavan-Shahraki, M Yousefifard, V Rahimi-Movaghar, M Baikpour, ... Scientific reports 8 (1), 325, 2018 | 64 | 2018 |
| The neuromodulatory effects of ω-3 fatty acids and nano-curcumin on the COX-2/iNOS network in migraines: A clinical trial study from gene expression to clinical symptoms M Abdolahi, A Jafarieh, P Sarraf, M Sedighiyan, A Yousefi, A Tafakhori, ... Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2019 | 61 | 2019 |
| Validation of the Persian version of the brief pain inventory (BPI-P) in chronic pain patients H Majedi, SS Dehghani, S Soleyman-Jahi, SAE Meibodi, ... Journal of pain and symptom management 54 (1), 132-138. e2, 2017 | 54 | 2017 |
| The combined effects of ω-3 fatty acids and nano-curcumin supplementation on intercellular adhesion molecule-1 (ICAM-1) gene expression and serum levels in migraine patients N Soveyd, M Abdolahi, M Djalali, M Hatami, A Tafakhori, P Sarraf, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2017 | 51 | 2017 |
| Identification of a Large DNAJB2 Deletion in a Family with Spinal Muscular Atrophy and Parkinsonism E Sanchez, H Darvish, R Mesias, S Taghavi, SG Firouzabadi, RH Walker, ... Human mutation 37 (11), 1180-1189, 2016 | 45 | 2016 |
| Bi-allelic variants in RNF170 are associated with hereditary spastic paraplegia M Wagner, DPS Osborn, I Gehweiler, M Nagel, U Ulmer, S Bakhtiari, ... Nature communications 10 (1), 4790, 2019 | 43 | 2019 |
| Identification of a large homozygous VPS13C deletion in a patient with early-onset Parkinsonism H Darvish, P Bravo, A Tafakhori, LJ Azcona, S Ranji-Burachaloo, ... Movement disorders: official journal of the Movement Disorder Society 33 (12 …, 2018 | 43 | 2018 |
| Sensing of Alzheimer’s disease and multiple sclerosis using nano-bio interfaces MJ Hajipour, F Ghasemi, H Aghaverdi, M Raoufi, U Linne, F Atyabi, ... Journal of Alzheimer's Disease 59 (4), 1187-1202, 2017 | 42 | 2017 |
Vajiheh AghamollaiiAssociate Professor of Neurology Tehran university of medical sciencesVerified email at sina.tums.ac.ir
